Search for: "SANOFI-PHARMACEUTICALS, INC."
Results 121 - 140
of 214
Sorted by Relevance
|
Sort by Date
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
5 Mar 2024, 10:55 am
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
17 Jun 2014, 6:15 pm
Inc., at *4-5 (internal citations omitted) (text added).Endo Pharmaceuticals, Inc. [read post]
22 Oct 2015, 8:42 am
IMS Health, Inc., 131 S. [read post]
15 Sep 2010, 2:15 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
2 Dec 2011, 2:00 pm
Qualitest Pharmaceuticals Inc., 2011 WL 334671, at *3 (E.D. [read post]
12 Dec 2008, 8:42 am
Ivax Pharmaceuticals, Inc., 501 F.3d 1263 (Fed. [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
20 Mar 2014, 9:13 pm
Sanofi-Adventis U.S. [read post]
31 Dec 2023, 4:29 pm
Copyright Fair Use Andy Warhol Foundation for the Visual Arts, Inc. v. [read post]
11 Apr 2019, 10:59 am
The compounds of the present invention can be combined with pharmaceutical carriers and administered in a variety of well-known pharmaceutical forms suitable for oral or parental administration to provide compositions useful in the treatment of cardiovascular disorders and particularly mammalian hypertension. (35) (citing Sanofi v Apotex/ramipril). [read post]
24 Sep 2010, 1:15 pm
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
25 May 2011, 8:52 pm
Therasense, Inc. v. [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
